Summit Therapeutics Share Discussion Threads

[waterloo01] 06/12/2019 12:15

They are tradable till 23rd Feb. Not sure if they can still be held in ISA/SIPP etc or if they automatically transfer as ADR's or have to be sold?

Will try and find out.

[leedslad001] 06/12/2019 12:12

What does that mean for our shares we hold what price do we get

[waterloo01] 06/12/2019 12:06

Well there it is. Delisting from AIM in Feb.

[waterloo01] 13/11/2019 19:22

Tweeted by Summit but a must read on our three targets. C.diff still killing 13,000 a year in the US.

[bermudashorts] 06/11/2019 19:59

Not sure whether this has already been posted but in case it hasn't, looks like Summit are presenting at the forthcoming China Healthcare Summit in Shanghai:-

'The 6th China Healthcare Summit will feature Road Show presentations to showcase private and public biotechs from China, Asia and the West. This will be a unique opportunity for companies to present in Shanghai to top China investors and biopharma CEOs, as well as domestic and multinational pharma licensing executives.

Presenting Companies are hand-picked by BioCentury and BayHelix based on rigorous selection criteria, including investor validation, upcoming milestones, unpartnered assets and innovative science.'

[waterloo01] 06/11/2019 18:43

This might be helpful



The Centers for Medicare and Medicaid Services — the federal agency I lead — has the responsibility of both caring for America’s seniors and serving as the largest health care payer in the country. The Trump administration is determined to unravel the regulations binding the hands of America’s innovators to resolve this public health crisis.

In the short-term, CMS has finalized an expanded pathway for certain new antibiotics to receive additional payments and to increase payments for them. This will help people who need these medications get access to them. The agency also updated its payments to hospitals to provide them with appropriate resources to treat sick patients with drug-resistant infections. We’re also committed to scaling up antibiotic stewardship protocols — clinical guidelines for antibiotic prescribing that CMS has already implemented in nursing homes — to hospitals, which is where the majority of patients with drug-resistant infections receive care.

In the long-term, CMS will lead a broader effort to modernize Medicare’s payment systems for antibiotics and other endangered innovations.

[chrisatrdg] 04/11/2019 12:28

RNS out:

Summit Therapeutics Recognises C. difficile Awareness Month

Company to Highlight Potential of Phase 3 Precision Antibiotic Ridinilazole at the 7th Annual C. diff. Conference and Health EXPO

[kirk 6] 01/11/2019 11:59

Can't we do a farn

[kirk 6] 29/10/2019 20:12

Nice close on the Nasdaq admittedly minimal volume

[wildbunch] 29/10/2019 12:43

Waterloo Agree he will not lit it fail-provided he still has the faith. Agree he may prefer to raise the cash elsewhere preferably on non dilutive basis-however my big fear is either that won't be his preference or he may just wish to take it over. The better it looks the more he might lean this way.

[chrisatrdg] 28/10/2019 15:31

GlaxoSmithKline kick-starts first-of-its-kind late-stage antibiotic test

[chrisatrdg] 28/10/2019 10:12

When next for Summit - this week?

Hi All,
There have been some interesting Buys in the last week & the NASDAQ is still ahead of AIM could this be the week we hear of new funding taking Summit beyond Jan 2020.Recent conferences have been of a high standard & I thought that Glyn was particularly chipper in the last interview as if a weight had been taken off his shoulders.

[waterloo01] 26/10/2019 07:21

Wildbunch yes you are correct he already owns 48.8% my mistake, but the point stands in that he can't go any higher, but equally isn't about to let it fail because of a shortage of cash.

[wildbunch] 25/10/2019 21:48

Waterloo-Thought Duggan took a circa 48% stake-did I get this wrong?

[chrisatrdg] 25/10/2019 19:31

Summit Therapeutics CEO says anti microbial resistance will be as big a problem as climate change

yy.co.uk/companies/news/905666/summit-therapeutics-ceo-says-anti-microbial-resistance-will-be-as-big-a-problem-as-climate-change-905666.html

X proactive yy investors

Edit: Worth a read Summit starting to get greater cover just a matter of waiting.

[kirk 6] 21/10/2019 20:40

Hedge using the Nasdaq as hold 1.4m U.K. short 10k shares Nasdaq as soon as I put a sell order out it gets filled Nasdaq is looking very strong tonight wants to snap up any share on offer

[kirk 6] 21/10/2019 16:29

Yes you keep saying I disagree if the market over on the pond has a deal we shoulda be watching the Nasdaq for volume and share price Nice volume today aswell

[waterloo01] 21/10/2019 15:13

Currently up and trading at 28p equivalent. Suspect the 20% discount on AIM won't last too long.

Wouldn't surprise me to see a raise at a premium, as last time. Dungan will bring in funds IMO and take part but will keep his holding below the 30% otherwise he might get forced into a bid, which I doubt is his intention.

Grant funding would be great as like Barda, it was non dilutive. We'll see but they will be able to raise, hopefully at the same time as there is a change in the general antibiotic environment.

[wildbunch] 21/10/2019 12:04

Read my earlier posts-big minority shareholder will not let this go-low share price makes buy out cheaper. This has nothing to do with NASDAQ or AIM-all to do with whether BOD get alternative financing PDQ-or do they really want to do so?

Time for people to wake up and smell the coffee.

Thats' all.

[kirk 6] 18/10/2019 21:42

It hit 1.79 just before close so might get toward $2. Good volume as well so if a deal has been negotiated with a partner it will no doubt be leaked over the pond. One to watch closely

[chrisatrdg] 18/10/2019 21:16

Interesting close on NASDAQ this evening $1.71 = £0.26p maybe kirk6 is right because Summit must come up with something soon otherwise non C-Diff work has to slow down in order to extend the cash runway.

[kirk 6] 18/10/2019 17:59

Looking for share price movements indicating a potential finance deal. Happened last time.U.K. normally follows Nasdaq

[wildbunch] 18/10/2019 13:11

Looking for what?